The Cann Group Ltd (ASX: CAN) share price has wobbled in morning trading on news the medicinal cannabis company received a tax refund for its research and development (R&D).
In early trade, the Cann Group share price was up as high as 70 cents. However, the price has since dropped 2.26% to currently trade at 65 cents.
What did Cann Group announce this morning?
In a release to the ASX this morning, Cann Group revealed it had received a $3.2 million tax refund for its R&D initiatives in the 2020 financial year.
Tax offsets are offered by the Australian government to businesses for certain R&D investments. Cann’s refund includes activities conducted by the company through partnerships with strategic research entities.
Cann reported it will reinvest the fund into the continued development of its expansion, commercial activities and product portfolio.
Commenting on the news, Cann Group CEO Peter Crock said:
The refund that we have received under the R&D tax incentive program is an indicator of the company’s commitment to research in the medicinal cannabis sector.
We’ve recently conducted a close review of these R&D programs to ensure we are prioritising our investment appropriately and will continue to see meaningful and beneficial outcomes from these activities.
Cann Group breeds, cultivates, produces, and manufactures cannabis for medicinal and research purposes. The company has established R&D and cultivation facilities in Australia to facilitate the supply of medicinal cannabis for a range of diseases and medical conditions.
Cann was the first company to be issued with a cannabis research licence by the Australian Federal Department of Health’s Office of Drug Control in February 2017. Shares of Cann first began trading on the ASX in May 2017.
About the Cann Group share price
The Cann Group share price is off to a strong start in 2021, up 14% since the opening bell on 4 January.
2020 saw shares also take off in the early weeks of trading, with the share price gaining more than 92% by 20 January. From there things went largely downhill, with shares plummeting 82% through to 20 November. Having begun to recover from the COVID-19 selloff, shares were put under renewed pressure in July when the company conducted a capital raising at a 50% discount to the share price at that time.
Things took a turn for the better in November when the company received approval for a $50 million debt facility from the National Australia Bank (ASX: NAB). Cann is using the funds to complete the first stage of its production site outside of Mildura, Victoria.
Over the past 12 months, the Cann Group share price is down 22%.
For comparison, the All Ordinaries Index (ASX: XAO) is up 1% in that same time.
Where to invest $1,000 right now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.
*Returns as of February 15th 2021
Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
- Here’s why the Nickel Mines (ASX:NIC) share price spiked 7% this afternoon – March 5, 2021 4:15pm
- Why ASX uranium shares could run even hotter in 2021 – March 5, 2021 3:16pm
- Fundie tips this ASX 200 retail share to prosper in 2021 – March 5, 2021 2:29pm